Gene · 2272
Papers2,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differentially expressed full-length, fusion and novel isoforms transcripts-based signature of well-differentiated keratinized oral squamous cell carcinoma. | Oncotarget | 2020 | 32922662 | PubTator, text mining | PubMed |
| Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis. | BMC Cancer | 2020 | 32907552 | PubTator, text mining | PubMed |
| Promoter methylation, transcription, and retrotransposition of LINE-1 in colorectal adenomas and adenocarcinomas. | Cancer Cell Int | 2020 | 32905102 | PubTator, text mining | PubMed |
| Current and Future Trends in Molecular Biomarkers for Diagnostic, Prognostic, and Predictive Purposes in Non-Melanoma Skin Cancer. | J Clin Med | 2020 | 32899768 | PubTator, text mining | PubMed |
| The Impact of Natural Dietary Compounds and Food-Borne Mycotoxins on DNA Methylation and Cancer. | Cells | 2020 | 32878338 | PubTator, text mining | PubMed |
| SCARLET: Single-cell tumor phylogeny inference with copy-number constrained mutation losses. | Cell Syst | 2020 | 32864481 | PubTator, text mining | PubMed |
| Up-regulation of DRAM2 promotes tolerance of bladder transitional cell carcinoma to gemcitabine. | Arch Med Sci | 2020 | 32864010 | PubTator, text mining | PubMed |
| Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer. | Cancer Res | 2020 | 32855208 | PubTator, text mining | PubMed |
| Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate. | Nat Commun | 2020 | 32839463 | PubTator, text mining | PubMed |
| Effect of genetic polymorphisms on therapeutic response in multiple sclerosis relapsing-remitting patients treated with interferon-beta. | Mutat Res Rev Mutat Res | 2020 | 32800273 | PubTator, text mining | PubMed |
| Programmed DNA Damage and Physiological DSBs: Mapping, Biological Significance and Perturbations in Disease States. | Cells | 2020 | 32785139 | PubTator, text mining | PubMed |
| Small RNAs, Big Diseases. | Int J Mol Sci | 2020 | 32784829 | PubTator, text mining | PubMed |
| The Potential of Phytochemicals in Oral Cancer Prevention and Therapy: A Review of the Evidence. | Biomolecules | 2020 | 32781654 | PubTator, text mining | PubMed |
| Nearest-Neighbor Projected Distance Regression for Epistasis Detection in GWAS With Population Structure Correction. | Front Genet | 2020 | 32774345 | PubTator, text mining | PubMed |
| The Pathologic and Molecular Landscape of Esophageal Squamous Cell Carcinogenesis. | Cancers (Basel) | 2020 | 32759723 | PubTator, text mining | PubMed |
| Epigenetic Silencing of LMX1A Contributes to Cancer Progression in Lung Cancer Cells. | Int J Mol Sci | 2020 | 32751497 | PubTator, text mining | PubMed |
| From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective. | Cancers (Basel) | 2020 | 32751137 | PubTator, text mining | PubMed |
| Development of MicroRNAs as Potential Therapeutics against Cancer. | J Oncol | 2020 | 32733559 | PubTator, text mining | PubMed |
| Accurate Detection of HPV Integration Sites in Cervical Cancer Samples Using the Nanopore MinION Sequencer Without Error Correction. | Front Genet | 2020 | 32714374 | PubTator, text mining | PubMed |
Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial-mesenchymal transition-related signaling pathways. | Carcinogenesis | 2020 | 32710740 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2272/papers?page=30